Janux Therapeutics
JANX
JANX
160 hedge funds and large institutions have $2.07B invested in Janux Therapeutics in 2024 Q3 according to their latest regulatory filings, with 32 funds opening new positions, 56 increasing their positions, 49 reducing their positions, and 27 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
3% more funds holding
Funds holding: 155 → 160 (+5)
1.21% more ownership
Funds ownership: 86.26% → 87.46% (+1.2%)
86% less call options, than puts
Call options by funds: $4.14M | Put options by funds: $29.8M
Holders
160
Holding in Top 10
3
Calls
$4.14M
Puts
$29.8M
Top Buyers
| 1 | +$59M | |
| 2 | +$38M | |
| 3 | +$32.8M | |
| 4 |
NNPTE
Nationale-Nederlanden Powszechne Towarzystwo Emerytalne
Warszawa,
Poland
|
+$21.4M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$13M |
Top Sellers
| 1 | -$78.2M | |
| 2 | -$24.9M | |
| 3 | -$18.5M | |
| 4 |
SC
Samlyn Capital
New York
|
-$13.6M |
| 5 |
APM
Avidity Partners Management
Dallas,
Texas
|
-$12.6M |